Marc Becker Apollo Dead or Alive? What Happened to Apollo Impact Partner and Co-Head?
In the age of rapid information dissemination through social media, baseless rumors can quickly gain momentum. Such is the case with the recent unfounded reports surrounding Marc Becker, a prominent figure in the business world and a Partner and Co-Head of Impact at Apollo. This article aims to dispel the death rumors and provide an in-depth exploration of Marc Becker’s career, accomplishments, and contributions.
Who Was Marc Becker?
Marc Becker, a distinguished individual with a career spanning over two decades, has played a pivotal role at Apollo. Serving as a Partner and Co-Head of Impact within the Private Equity division, Becker has demonstrated extensive expertise in various industry verticals. His responsibilities included overseeing private equity endeavors across sectors such as business services, transportation & logistics, financial services, payments, real estate services, home builders, and building products.
At 47 years old, Marc Becker has achieved remarkable success. He has been the Chairman of the Board of ADT Inc since 2016. His leadership and influence are reflected in the company’s growth and development.
Marc Becker’s impact extends beyond his tenure at Apollo. He has served on the Investment Committee for the private equity division and chairs the Investment Committee overseeing Apollo’s real estate private equity ventures in the United States and Asia. Furthermore, Becker holds the position of Chair at ADT Corporation, demonstrating his leadership and influence in various realms.
Before joining Apollo, Marc Becker honed his skills in the Investment Banking division of Smith Barney Inc. He is an alumnus of the University of Pennsylvania’s Wharton School of Business. His professional journey has been marked by numerous valuable contributions as a board member in companies like Sun Country Airlines, Realogy Corporation, Affinion Group Holdings, Inc., CEVA Holdings, LLC, Evertec Group, LLC, National Financial Partners, Novitex Holdings, Inc., and more.
Marc Becker’s involvement goes beyond the corporate world. He chairs the board of The TEAK Fellowship and Park Avenue Synagogue and holds a position on the University of Pennsylvania’s undergraduate financial aid leadership council. His dedication to nonprofit organizations exemplifies his commitment to making a positive impact beyond business.
What Happened to Marc Becker?
Recent online chatter about Marc Becker’s death was triggered by a single tweet that subsequently spread across multiple forums and news aggregators. However, thorough investigation revealed that these rumors were entirely baseless. Such instances underscore the need for accurate fact-checking in today’s interconnected world.
Marc Becker Apollo Net Worth
In the world of finance and business, Marc Becker, the Chief Financial Officer of Concert Pharmaceuticals, Inc, has made significant strides. This article delves into Marc Becker’s financial status, particularly his net worth, insider trading activities, and transactions within Concert Pharmaceuticals, Inc.
As of the latest available data, Marc Becker’s estimated net worth stands at approximately $696.32K. This financial estimation reflects his position as the Chief Financial Officer of Concert Pharmaceuticals, Inc, a role that has contributed to his overall wealth.
Ownership of Concert Pharmaceuticals, Inc Common Stock
Marc Becker holds ownership of around 123,863 units of Concert Pharmaceuticals, Inc common stock. This ownership signifies his vested interest in the company’s performance and future prospects.
Insider Trading Activities
Over the course of the past 4 years at Concert Pharmaceuticals, Inc, Marc Becker has engaged in several insider trading transactions, shedding light on his investment decisions and interactions with the company’s stock.
Overview of Past Transactions
Marc Becker’s insider trading history showcases a total of about 13 transactions during his tenure at Concert Pharmaceuticals, Inc. These transactions have taken place over the span of 4 years, providing insight into his trading patterns and market engagement.
Significant Sale Orders
One of the most noteworthy sale orders by Marc Becker involved 8,493 units of Concert Pharmaceuticals, Inc common stock, with an approximate value exceeding $70.92K. This substantial sale exemplifies his proactive approach to managing his investments.
Trading Trends and Busy Year
Marc Becker tends to carry out trading activities predominantly in January, with the year 2023 being particularly active. This trading trend provides insights into his strategic decision-making regarding stock transactions.
Recent Transaction
In one of his more recent transactions, Marc Becker executed a sale order of 3,762 units of Concert Pharmaceuticals, Inc common stock, valued at over $31.34K. This transaction, which took place on February 16, 2023, contributes to the evolving narrative of his investment activities.
Marc Becker’s financial journey as the Chief Financial Officer of Concert Pharmaceuticals, Inc is characterized by ownership of significant common stock units and a series of insider trading transactions. His engagement in the company’s stock reflects his active role in shaping its financial trajectory. The provided insights into Marc Becker’s net worth, stock ownership, and trading patterns offer a glimpse into his financial involvement within the realm of Concert Pharmaceuticals, Inc.
Conclusion
The recent unfounded rumors surrounding Marc Becker’s passing highlight the need for caution in an era where misinformation can spread rapidly. By dispelling these rumors, we can appreciate Marc Becker’s significant contributions to both the business world and the realm of nonprofit organizations. His achievements, leadership roles, and dedication to making a positive impact serve as a testament to his enduring legacy.
